NFKappaB-p65 Polyclonal Antibody, 100ul[BT-AP05993] Peptide Synthesis which causes reduced sclerostin expression

which causes reduced sclerostin expression

Alternatively spliced transcript variants encoding the same protein have been found for CLDN5

Mutations in this gene have been associated with autosomal recessive congenital fibrosis of the extraocular muscles

attachment

NFKappaB-p65 Polyclonal Antibody, 100ul[BT-AP05993] Peptide Synthesis which causes reduced sclerostin expressionNF kappa B is a ubiquitous transcription factor involved in several biological processes. It is held in the cytoplasm in an inactive state by specific inhibitors. Upon degradation of the inhibitor, NF kappa B moves to the nucleus and activates transcription of specific genes. NF kappa B is composed of NFKB1 or NFKB2 bound to either REL, RELA, or RELB. The most abundant form of NF kappa B is NFKB1 complexed with the product of RELA, RELA. Four